Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
16.84
-0.41 (-2.38%)
At close: Jun 6, 2025, 4:00 PM
17.19
+0.35 (2.08%)
After-hours: Jun 6, 2025, 7:02 PM EDT
Eton Pharmaceuticals Employees
Eton Pharmaceuticals had 31 employees as of December 31, 2024. The number of employees increased by 1 or 3.33% compared to the previous year.
Employees
31
Change (1Y)
1
Growth (1Y)
3.33%
Revenue / Employee
$1,558,935
Profits / Employee
-$147,871
Market Cap
451.61M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ETON News
- 8 days ago - FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue - Benzinga
- 9 days ago - Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution - GlobeNewsWire
- 16 days ago - Eton Pharmaceuticals Set To Dominate Orphan Drug Niche - Seeking Alpha
- 23 days ago - Eton Pharmaceuticals to Participate at Upcoming Investor Conferences - GlobeNewsWire
- 23 days ago - Eton Pharmaceuticals, Inc. (ETON) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Eton Pharmaceuticals Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025 - GlobeNewsWire
- 5 weeks ago - Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution) - GlobeNewsWire